FTXH · First Trust Nasdaq Pharmaceuticals ETF

Equity fundTracks an index0.60% fee$1.0bnSince Sep 22, 2016Fund page at the issuer ↗SEC filings ↗

FTXH tracks an index and returned +39.1% over the past year.

+39.1%
Total return, 1 year
0.60%
Expense ratio
51
Holdings
−4.7%
Below its high
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3M Jul 2 – Oct 2, 2026+4.1%+3.6%+0.5 pts−1.2 pts
6M Apr 2 – Oct 2, 2026+19.4%+17.9%+1.5 pts−9.0 pts
1Y Oct 2, 2025 – Oct 2, 2026+39.1%+16.2%+22.9 pts+14.8 pts
3Y Oct 3, 2023 – Oct 2, 2026+68.6%+89.3%−20.7 pts−46.2 pts
Since listing Sep 22, 2016 – Oct 2, 2026+125.8%+315.3%−189.5 pts−448.7 pts

FTXH over each window to Oct 2, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.

FTXH top ten by weight, 53.9% of its 51 equity positions, from the holdings published by its issuer for Oct 2, 2026. An index fund holds what the index holds, so this is the index. Source: the issuer’s own daily file.

AbbVie Inc. ABBV 7.46%
Eli Lilly and Company LLY 7.19%
Merck & Co., Inc. MRK 7.11%
Pfizer Inc. PFE 7.11%
Viatris Inc. VTRS 3.88%
Biogen Inc. BIIB 3.69%
Gilead Sciences, Inc. GILD 3.60%
United Therapeutics Corporation UTHR 3.43%
Amgen Inc. AMGN 3.41%

In plain words

FTXH tracks an index. Over the year to Oct 2, 2026 it returned +39.1% with distributions reinvested, against +16.2% for the S&P 500 and +24.3% for the Nasdaq-100. The prospectus expense ratio is 0.60% a year. By its holdings published by its issuer for Oct 2, 2026, 68% of the fund by weight is stocks the S&P 500 also holds, across 51 positions, with the top ten at 53.9%. It sat 4.7% below its high of Aug 25, 2026 on Oct 2, 2026.
What it tracksnot read by ETFIQ
Fund typeEquity fund
Category (ETFIQ)Stocks · Health care
Expense ratio (485BPOS XBRL, Jul 29, 2026)0.60%
Price$40.73
Listed sinceSep 22, 2016
Net assets (issuer page, as of Oct 2, 2026)$1.0bn
Below its high (ETFIQ)−4.7%
Holdings51
Top ten weight53.9%
Holdings published for (the issuer’s daily file)Oct 2, 2026
Already in the S&P 500, by weight (ETFIQ)68.1%
Active share vs the S&P 500 (ETFIQ)94.9%
Already in the Nasdaq-100, by weight (ETFIQ)12.6%
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Questions people ask about FTXH

How has FTXH performed?
Over the year to Oct 2, 2026, FTXH returned +39.1% with distributions reinvested, against +16.2% for the S&P 500. Over three years the figure is +68.6%.
What does FTXH cost?
The prospectus expense ratio is 0.60% a year.
What does FTXH hold?
51 positions as published by its issuer for Oct 2, 2026, with the top ten at 53.9% of the fund. 68% of its weight is in stocks the S&P 500 also holds.
How far is FTXH below its high?
4.7% below its high of Aug 25, 2026, measured on the reinvested series to Oct 2, 2026.
Sources and dates
Prices, FTXH and S&P 500Tiingo end-of-day · Oct 2, 2026
Net assets, $1.0bnIssuer page · Oct 2, 2026

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ETFIQ covers core, leveraged and inverse, buffer, thematic, option-income, alternatives and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources

Cite this page

ETFIQ, FTXH, core fund, data as of Oct 2, 2026. https://etfiq.com/funds/ftxh

Free to use with attribution; the underlying files are at Open data.